Immunohistochemical Detection of CD147 Expression in Adenocarcinoma of the Prostate: A Case-Control Study
Prostate cancer is the most common noncutaneous malignancy among men worldwide, including in Sudan, where it represents a significant public health challenge. CD147, a transmembrane glycoprotein implicated in tumor progression, invasion, and metastasis, has shown potential as a prognostic biomarker...
Saved in:
| Main Authors: | Sara Suliman, Mona Ellaithi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Prostate Cancer |
| Online Access: | http://dx.doi.org/10.1155/proc/4406057 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD44 Immunohistochemical Expression in Central and Peripheral Parts of Prostatic Adenocarcinoma: An Institutional Study
by: Romano Oguic, et al.
Published: (2024-12-01) -
Specific immunohistochemical expression of Mmp-26 in prostatic adenocarcinoma
by: ROMILDO LUCIANO DA SILVA, et al.
Published: (2025-01-01) -
Relationship of Immunohistochemical Expression of CD86/CD163 Positive Intratumoral Macrophages with Prognosis of Pancreatic Ductal Adenocarcinoma
by: Goran Glavčić, et al.
Published: (2024-01-01) -
CD147-expressed small extracellular vesicles enhance the detection of colorectal neoplasia with fecal immunochemical test
by: L.-C. Chang, et al.
Published: (2025-03-01) -
Immunohistochemical study of VEGF-A, VEGFR-1, VEGFR-2 and CD34 expression in сolorectal adenocarcinoma progression
by: M. A. Shyshkin
Published: (2019-09-01)